https://orcid.org/0000-0002-1841-5584
Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mohammad Mehdi Ghorbani, Touraj Farazmandfar, Saeid Abediankenari, Hadi Hassannia, Zahra Maleki & Majid Shahbazi. (2022) Treatment of EAE Mice with Treg, G-MDSC and IL-2: a New Insight into Cell Therapy for Multiple Sclerosis. Immunotherapy 14:10, pages 789-798.
Read now
Read now
Agustinus Darmadi Hariyanto, Tiara Bunga Mayang Permata & Soehartati Argadikoesoema Gondhowiardjo. (2022) Role of CD4+CD25+FOXP3+ TReg cells on tumor immunity. Immunological Medicine 45:2, pages 94-107.
Read now
Read now
Amit Verma, Amitava Adhikary, Gayle Woloschak, Bilikere S. Dwarakanath & Rao V. L. Papineni. (2020) A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management. International Journal of Radiation Biology 96:11, pages 1323-1328.
Read now
Read now
Articles from other publishers (51)
Yuan-jie Liu, Jie-pin Li, Ying Zhang, Yi Yin, Shen-lin Liu & Xi Zou. (2024) Comprehensive analysis to evaluate the molecular biological mechanism and clinical efficacy of Jian Pi Yang Zheng Xiao Zheng in the treatment of gastric cancer. Pharmacological Research - Modern Chinese Medicine 10, pages 100379.
Crossref
Crossref
Prashant Sharma & Mario Otto. (2024) Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy. Bioactive Materials 31, pages 440-462.
Crossref
Crossref
Sikiru O. Imodoye & Kamoru A. Adedokun. (2023) EMT-induced immune evasion: connecting the dots from mechanisms to therapy. Clinical and Experimental Medicine 23:8, pages 4265-4287.
Crossref
Crossref
Henrik Rönnberg. 2023. Therapeutic Strategies in Veterinary Oncology. Therapeutic Strategies in Veterinary Oncology
89
110
.
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, Martina Perrone, Assunta Melaccio, Pierluigi De Santis, Anna Natalizia Santoro, Chiara Guarini, Maria Laura Iaia & Palma Fedele. (2023) Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology 30:6, pages 5769-5794.
Crossref
Crossref
Fan Gao, JianHui Dong, Chun Xue, Lei An, Tian Zhang, Wen-Jun Wang, ChangJin Ou & XiaoChen Dong. (2023) Nanomaterials-involved strategies for reversing the immunosuppressive factors and improving antitumor immunotherapy. Nano Today 50, pages 101831.
Crossref
Crossref
Jiahui Liu, Rong Sheng Li, Lei Zhang, Jie Wang, Qi Dong, Zhigang Xu, Yuejun Kang & Peng Xue. (2023) Enzyme‐Activatable Polypeptide for Plasma Membrane Disruption and Antitumor Immunity Elicitation. Small 19:24.
Crossref
Crossref
Zhufeng Li, Fang Yuan, Xin Liu, Jianming Wei, Tong Liu, Weidong Li & Chuan Li. (2023) Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer. Frontiers in Oncology 13.
Crossref
Crossref
Juvin Ann Thomas, Athira Gireesh Gireesh Moly, Hima Xavier, Priya Suboj, Amit Ladha, Gaurav Gupta, Santosh Kumar Singh, Partha Palit & Suboj Babykutty. (2023) Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?. Frontiers in Oncology 13.
Crossref
Crossref
Farhad Seif, Zahra Torki, Hamidreza Zalpoor, Mehran Habibi & Majid Pornour. (2023) Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. Molecular Therapy - Oncolytics 28, pages 132-157.
Crossref
Crossref
Stavroula Bernitsa, Rotem Dayan, Anastasis Stephanou, Iva D. Tzvetanova & Ioannis S. Patrikios. (2023) Natural biomolecules and derivatives as anticancer immunomodulatory agents. Frontiers in Immunology 13.
Crossref
Crossref
Chaofu Ma, Ouwen Qiu, Chengying Huang, Jing Huang & Shanqiang Qu. (2023) Roles of Tenascin-XB in the Glioma Immune Microenvironment. BIO Integration 4:1.
Crossref
Crossref
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana & Ajay Rana. 2023. Pancreatic Cancer: Basic Mechanisms and Therapies. Pancreatic Cancer: Basic Mechanisms and Therapies
113
143
.
Justin Z. Wang, Farshad Nassiri, Linda Bi & Gelareh Zadeh. 2023. Biological and Clinical Landscape of Meningiomas. Biological and Clinical Landscape of Meningiomas
189
198
.
Aleksey S. Bulygin, Julia N. Khantakova, Nadezhda S. Shkaruba, Hiroshi Shiku & Sergey S. Sennikov. (2022) The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity. Frontiers in Immunology 13.
Crossref
Crossref
C. T. Mierke. 2022. Biomaterial Based Approaches to Study the Tumour Microenvironment. Biomaterial Based Approaches to Study the Tumour Microenvironment
60
96
.
Shokoofe Noori, Mitra Nourbakhsh, Hossein Imani, Niloofar Deravi, Niloufar Salehi & Zohreh Abdolvahabi. (2022) Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer. BMC Complementary Medicine and Therapies 22:1.
Crossref
Crossref
Emily Cassar, Apriliana E. R. Kartikasari & Magdalena Plebanski. (2022) Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities. Cancers 14:22, pages 5488.
Crossref
Crossref
Bayley R. McRitchie & Billur Akkaya. (2022) Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment. Frontiers in Immunology 13.
Crossref
Crossref
Sultana Mehbuba Hossain, Gregory Gimenez, Peter A. Stockwell, Peter Tsai, Cristin G. Print, Janusz Rys, Bozena Cybulska-Stopa, Magda Ratajska, Agnieszka Harazin-Lechowska, Suzan Almomani, Christopher Jackson, Aniruddha Chatterjee & Michael R. Eccles. (2022) Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Frontiers in Immunology 13.
Crossref
Crossref
Abhishek Dutta & Swastika Paul. (2022) Exosome‐based cancer stem cell communication: Implication for detecting and eliminating cancer stem cells. MedComm – Future Medicine 1:2.
Crossref
Crossref
Mitesh Dwivedi, Sanjay Tiwari, E. Helen Kemp & Rasheedunnisa Begum. (2022) Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. Heliyon 8:8, pages e10450.
Crossref
Crossref
Yuchen Du, Yuan Guo, Xuan Xiao, Xiaonan Zhu, Ye Liu, Xiuhang Ruan, Xiaofei Huang, Youyong Yuan & Xinhua Wei. (2022) Glutathione depletion and photosensitizer activation augments efficacy of tumor photodynamic immunotherapy. Chemical Engineering Journal 442, pages 136170.
Crossref
Crossref
Pengfei Xu, Logan J. Wasielewski, Joy C. Yang, Demin Cai, Christopher P. Evans, William J. Murphy & Chengfei Liu. (2022) The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer. Biomedicines 10:8, pages 1778.
Crossref
Crossref
Agnieszka Krzywdzińska, Bartosz Puła, Donata Szymczak, Aneta Milanowska, Agnieszka Szeremet & Krzysztof Jamroziak. (2022) Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma. Journal of Clinical Medicine 11:13, pages 3722.
Crossref
Crossref
Seong Keun Kim & Sun Wook Cho. (2022) The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Frontiers in Pharmacology 13.
Crossref
Crossref
Rama Rao Malla, Padmaraju Vasudevaraju, Rahul Kumar Vempati, Marni Rakshmitha, Neha Merchant & Ganji Purnachandra Nagaraju. (2022) Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis. Cancer 128:6, pages 1171-1183.
Crossref
Crossref
Elgin Hoffmann, Frank Paulsen, Philipp Schaedle, Daniel Zips, Cihan Gani, Hans-Georg Rammensee, Cécile Gouttefangeas & Franziska Eckert. (2021) Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer. Cancer Immunology, Immunotherapy 71:3, pages 541-552.
Crossref
Crossref
Kavya Venkateswaran, Amit Verma & Bilikere S. Dwarakanath. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
799
815
.
Kavya Venkateswaran, Amit Verma & Bilikere S. Dwarakanath. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
17
.
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, Chike O. Abana, Kewen He, Duygu Sezen, Mark Wasley, Fatemeh Masrorpour, Dawei Chen, Liangpeng Yang, Joe D. Dunn, Saumil Gandhi, Quynh-Nhu Nguyen, Maria Angelica Cortez & James W. Welsh. (2021) A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Alexandra C. Costa, Joana M.O. Santos, Rui M. Gil da Costa & Rui Medeiros. (2021) Impact of immune cells on the hallmarks of cancer: A literature review. Critical Reviews in Oncology/Hematology 168, pages 103541.
Crossref
Crossref
Smita Kumari, Dia Advani, Sudhanshu Sharma, Rashmi K. Ambasta & Pravir Kumar. (2021) Combinatorial therapy in tumor microenvironment: Where do we stand?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188585.
Crossref
Crossref
Eslam E. Abd El-Fattah & Amir Mohamed Abdelhamid. (2021) Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung. Toxicology 463, pages 152994.
Crossref
Crossref
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami, Mehrdad Fathi, Mehran Mohammadpour Saray, Leili Aghebati-Maleki, Reza Jafari, Naime Majidi Zolbanin & Farhad Jadidi-Niaragh. (2021) The role of regulatory T cells in the pathogenesis and treatment of prostate cancer. Life Sciences 284, pages 119132.
Crossref
Crossref
Daniel Hirschhorn, Allison Betof Warner, Rachana Maniyar, Andrew Chow, Levi M.B. Mangarin, Adam D. Cohen, Linda Hamadene, Gabrielle A. Rizzuto, Sadna Budhu, Nathan Suek, Cailian Liu, Alan N. Houghton, Taha Merghoub & Jedd D. Wolchok. (2021) Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness. JCI Insight 6:20.
Crossref
Crossref
Christina Hadjiaggelidou & Eirini Katodritou. (2021) Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment. Journal of Clinical Medicine 10:19, pages 4588.
Crossref
Crossref
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, Jorrit De Waele & An Wouters. (2021) The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies. Frontiers in Immunology 12.
Crossref
Crossref
Varun Sasidharan Nair, Reem Saleh, Salman M. Toor, Farhan S. Cyprian & Eyad Elkord. (2021) Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment. Cancer Immunology, Immunotherapy 70:8, pages 2103-2121.
Crossref
Crossref
Sultana Mehbuba Hossain, Chiemi F. Lynch-Sutherland, Aniruddha Chatterjee, Erin C. Macaulay & Michael R. Eccles. (2021) Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?. Epigenomes 5:3, pages 16.
Crossref
Crossref
Pablo A. Vieyra-Garcia & Peter Wolf. (2021) A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacology & Therapeutics 222, pages 107784.
Crossref
Crossref
Sherif E. Emam, Nehal E. Elsadek, Amr S. Abu Lila, Haruka Takata, Yoshino Kawaguchi, Taro Shimizu, Hidenori Ando, Yu Ishima & Tatsuhiro Ishida. (2021) Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. Journal of Controlled Release 334, pages 327-334.
Crossref
Crossref
Gagan Chhabra, Chandra K. Singh, Deeba Amiri, Neha Akula & Nihal Ahmad. (2021) Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment. Molecules 26:5, pages 1343.
Crossref
Crossref
Harold L. Lazar. (2021) Commentary: Suppressing the inflammatory response—can it be an alternative to surgical aortic valve replacement and transcatheter aortic valve replacement for patients with calcific aortic stenosis?. JTCVS Open 5, pages 13-14.
Crossref
Crossref
Bilguun Erkhem-Ochir, Wataru Tatsuishi, Takehiko Yokobori, Tsukasa Ohno, Kyohei Hatori, Tadashi Handa, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki & Tomonobu Abe. (2021) Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis. JTCVS Open 5, pages 1-12.
Crossref
Crossref
Liwei Jiang, Sungwook Jung, Jing Zhao, Vivek Kasinath, Takaharu Ichimura, John Joseph, Paolo Fiorina, Andrew S. Liss, Khalid Shah, Nasim Annabi, Nitin Joshi, Tomoya O. Akama, Jonathan S. Bromberg, Motohiro Kobayashi, Kenji Uchimura & Reza Abdi. (2021) Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery. Nano Today 36, pages 101045.
Crossref
Crossref
Xiaoyang Wang, Maria Jaimes, Huimin Gu, Keith Shults, Santosh Putta, Vishal Sharma, Will Chow, Priya Gogoi, Kalyan Handique & Bruce K Patterson. (2021) Cell by cell immuno- and cancer marker profiling of non-small cell lung cancer tissue: Checkpoint marker expression on CD103+, CD4+ T-cells predicts circulating tumor cells. Translational Oncology 14:1, pages 100953.
Crossref
Crossref
Stephanie Annett, Gillian Moore & Tracy Robson. (2020) Obesity and Cancer Metastasis: Molecular and Translational Perspectives. Cancers 12:12, pages 3798.
Crossref
Crossref
Amirhossein Jahangiri, Maryam Dadmanesh & Khodayar Ghorban. (2020) STAT3 inhibition reduced PD‐L1 expression and enhanced antitumor immune responses. Journal of Cellular Physiology 235:12, pages 9457-9463.
Crossref
Crossref
Yolla Haibe, Ziad El Husseini, Rola El Sayed & Ali Shamseddine. (2020) Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review. International Journal of Molecular Sciences 21:17, pages 6176.
Crossref
Crossref
Wataru Takenaka, Yutaka Takahashi, Keisuke Tamari, Kazumasa Minami, Shohei Katsuki, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi & Kazuhiko Ogawa. (2020) Radiation Dose Escalation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers 12:6, pages 1546.
Crossref
Crossref